12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Portrait Toxigenic Clostridium difficile Assay regulatory update

Great Basin said FDA granted 510(k) clearance for its Portrait Toxigenic Clostridium difficile Assay to diagnose C. difficile infection in stool...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >